H. Autorité and D. Santé, Sclérose en plaques Guide Affection de longue durée, 2006.

A. Fromont, C. Binquet, E. Sauleau, I. Fournel, A. Bellisario et al., Geographic variations of multiple sclerosis in France, Brain, vol.133, issue.7, pp.1889-99, 2010.
DOI : 10.1093/brain/awq134

J. Grimaud and J. Auray, L?????valuation m??dico-??conomique dans la scl??rose en plaques, Revue Neurologique, vol.160, issue.1, pp.23-34
DOI : 10.1016/S0035-3787(04)70844-9

D. Brassat, Physiopathologie de la sclérose en plaques. Presse Médicale, pp.341-349, 2010.

A. Fromont and T. Moreau, Sclérose en plaques. Rev Prat, Juin, vol.63, pp.851-860, 2013.

D. Seze, J. Confavreux, and C. , Multiple sclerosis: positive diagnosis]. Rev Prat, Jun, vol.3056, issue.12, pp.1321-1326, 2006.

J. Ouallet and B. Brochet, Aspects cliniques, physiopathologiques, et thérapeutiques de la sclérose en plaques. EMC -Neurol, pp.415-57, 2004.

G. Defer, B. Brochet, J. Pelletier, G. Defer, B. Brochet et al., Chapitre 2 -Symptômes, formes, évolution Available from, Neuropsychologie de la sclérose en plaques [Internet], pp.11-20, 2010.

J. Kurtzke, Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), Neurology, vol.33, issue.11, pp.1444-52, 1983.
DOI : 10.1212/WNL.33.11.1444

J. Kurtzke, On the origin of EDSS, Multiple Sclerosis and Related Disorders, vol.4, issue.2, pp.95-103
DOI : 10.1016/j.msard.2015.02.003

D. Chabas, Progr??s r??cents concernant les m??canismes immunitaires de la scl??rose en plaques, Revue Neurologique, vol.162, issue.2, pp.162-73, 2006.
DOI : 10.1016/S0035-3787(06)74996-7

M. Salou, E. Ngono, A. Garcia, A. Michel, L. Laplaud et al., Adaptative immunity and pathophysiology of multiple sclerosis]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.479-86, 2013.

N. Grigoriadis and V. Van-pesch, A basic overview of multiple sclerosis immunopathology, European Journal of Neurology, vol.9, issue.248, pp.3-13
DOI : 10.1111/ene.12798

S. Baranzini and S. Hauser, Large-scale gene-expression studies and the challenge of multiple sclerosis, Genome Biol, vol.3, issue.10, p.1027, 2002.

B. Brochet, La part de l???inflammation dans la pathog??nie de la scl??rose en plaques, Pratique Neurologique - FMC, vol.6, issue.2, pp.156-165
DOI : 10.1016/j.praneu.2015.01.007

K. Blauth, J. Soltys, A. Matschulat, C. Reiter, A. Ritchie et al., Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants, Acta Neuropathologica, vol.70, issue.6, p.2015
DOI : 10.1007/s00401-015-1500-6

B. Wootla, A. Denic, B. Keegan, J. Winters, D. Astapenko et al., Evidence for the Role of B Cells and Immunoglobulins in the Pathogenesis of Multiple Sclerosis, Neurology Research International, vol.16, issue.10, p.780712, 2011.
DOI : 10.1016/j.nbd.2006.06.012

M. Weber, B. Hemmer, and S. Cepok, The role of antibodies in multiple sclerosis, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1812, issue.2, pp.239-284, 2011.
DOI : 10.1016/j.bbadis.2010.06.009

K. Lauer, The intrathecal immune response in multiple sclerosis: A different concept of ???specificity???, Medical Hypotheses, vol.31, issue.4, pp.245-51, 1990.
DOI : 10.1016/0306-9877(90)90014-6

P. Lalive, M. Schluep, M. Chofflon, D. Pasquier, and R. , Immunity and neurodegeneration: new concepts in multiple sclerosis]. Rev Médicale Suisse, pp.1166-1174, 1170.

D. Hooper, O. Bagasra, J. Marini, A. Zborek, S. Ohnishi et al., Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis, Proceedings of the National Academy of Sciences, vol.94, issue.6, pp.2528-2561, 1997.
DOI : 10.1073/pnas.94.6.2528

A. Bitsch, J. Schuchardt, S. Bunkowski, T. Kuhlmann, and W. Brück, Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation, Brain, vol.123, issue.6, pp.1174-83, 2000.
DOI : 10.1093/brain/123.6.1174

M. Bonnan, Intrathecal immune reset in multiple sclerosis: exploring a new concept. Med Hypotheses, pp.300-309, 2014.

M. Bonnan, Organes lympho??des tertiaires m??ning??s??: des acteurs majeurs de l???auto-immunit?? intrath??cale, Revue Neurologique, vol.171, issue.1, pp.65-74
DOI : 10.1016/j.neurol.2014.08.003

B. Popescu and C. Lucchinetti, Meningeal and cortical grey matter pathology in multiple sclerosis, BMC Neurology, vol.133, issue.Pt 3, p.11, 2012.
DOI : 10.1093/brain/awp335

T. Holmøy, The discovery of oligoclonal bands: a 50-year anniversary, Eur Neurol, vol.62, issue.5, pp.311-316, 2009.

K. Blauth, J. Soltys, A. Matschulat, C. Reiter, A. Ritchie et al., Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants, Acta Neuropathologica, vol.70, issue.6, 2015.
DOI : 10.1007/s00401-015-1500-6

G. Owens, J. Bennett, H. Lassmann, O. Connor, K. Ritchie et al., Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid, Annals of Neurology, vol.204, issue.6, pp.639-688, 2009.
DOI : 10.1002/ana.21641

C. Jacobi, P. Lange, and H. Reiber, Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: Discrimination between microorganism-driven and polyspecific immune response, Journal of Neuroimmunology, vol.187, issue.1-2, pp.139-185, 2007.
DOI : 10.1016/j.jneuroim.2007.04.002

C. Poser, D. Paty, L. Scheinberg, W. Mcdonald, F. Davis et al., New diagnostic criteria for multiple sclerosis: Guidelines for research protocols, Annals of Neurology, vol.122, issue.3, pp.227-258, 1983.
DOI : 10.1002/ana.410130302

W. Mcdonald, A. Compston, G. Edan, D. Goodkin, H. Hartung et al., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, Annals of Neurology, vol.70, issue.1, 2001.
DOI : 10.1002/ana.1032

C. Polman, S. Reingold, G. Edan, M. Filippi, H. Hartung et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the ???McDonald Criteria???, Annals of Neurology, vol.6, issue.6, pp.840-846, 2005.
DOI : 10.1002/ana.20703

C. Polman, S. Reingold, B. Banwell, M. Clanet, J. Cohen et al., Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, pp.292-302, 2011.
DOI : 10.1002/ana.22366

X. Montalban, J. Sastre-garriga, M. Filippi, Z. Khaleeli, N. Téllez et al., Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler Houndmills Basingstoke Engl, pp.1459-65, 2009.

B. Brochet, Etude du liquide céphalorachidien dans la sclérose en plaques, pp.5-11, 2008.

J. Pelletier, Is it always useful to perform lumbar puncture for the diagnosis of multiple sclerosis? No], Rev Neurol, vol.171, pp.8-9607, 2015.

H. Tumani, F. Deisenhammer, G. Giovannoni, R. Gold, H. Hartung et al., Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis, Annals of Neurology, vol.70, issue.3, pp.520-521, 2011.
DOI : 10.1002/ana.22508

H. Link and Y. Huang, Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness, Journal of Neuroimmunology, vol.180, issue.1-2, pp.17-28, 2006.
DOI : 10.1016/j.jneuroim.2006.07.006

D. Miller, D. Chard, and O. Ciccarelli, Clinically isolated syndromes, The Lancet Neurology, vol.11, issue.2, pp.157-69, 2012.
DOI : 10.1016/S1474-4422(11)70274-5

URL : https://hal.archives-ouvertes.fr/hal-00552764

J. Masjuan, J. Alvarez-cermeño, N. García-barragán, M. Díaz-sánchez, M. Espiño et al., Clinically isolated syndromes: A new oligoclonal band test accurately predicts conversion to MS, Neurology, vol.66, issue.4, pp.576-584, 2006.
DOI : 10.1212/01.wnl.0000198253.35119.83

M. Tintoré, A. Rovira, J. Río, C. Tur, R. Pelayo et al., Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology, pp.1079-83, 2008.

J. Kuhle, G. Disanto, R. Dobson, R. Adiutori, L. Bianchi et al., Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Mult Scler Houndmills Basingstoke Engl, pp.1013-1037, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01139819

I. Boscá, M. Magraner, F. Coret, J. Álvarez-cermeño, M. Simó-castelló et al., The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands, Journal of Neuroimmunology, vol.226, issue.1-2, pp.143-149, 2010.
DOI : 10.1016/j.jneuroim.2010.05.032

R. Dobson, S. Ramagopalan, A. Davis, and G. Giovannoni, Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude, Journal of Neurology, Neurosurgery & Psychiatry, vol.9, issue.(5), 2013.
DOI : 10.1136/jnnp-2012-304695

A. Ruet, M. Deloire, J. Ouallet, S. Molinier, and B. Brochet, Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome. Mult Scler Houndmills Basingstoke Engl, pp.312-320, 2011.

A. Ruet, G. Arrambide, B. Brochet, C. Auger, E. Simon et al., Early predictors of multiple sclerosis after a typical clinically isolated syndrome. Mult Scler Houndmills Basingstoke Engl, pp.1721-1727, 2014.

H. Zéphir, E. Bodiguel, C. Bensa, F. Blanc, D. Laplaud et al., Recommendations for a definition of multiple sclerosis in support of early treatment, Revue Neurologique, vol.168, issue.4, pp.328-365
DOI : 10.1016/j.neurol.2011.12.008

C. Caudie, Le diagnostic biologique de la sclérose en plaques en 2012, Feuill Biol, vol.LIII, issue.308, pp.21-27, 2012.

A. Regeniter, J. Kuhle, M. Mehling, H. Möller, U. Wurster et al., A modern approach to CSF analysis: Pathophysiology, clinical application, proof of concept and laboratory reporting, Clinical Neurology and Neurosurgery, vol.111, issue.4, pp.313-321, 2009.
DOI : 10.1016/j.clineuro.2008.12.004

B. Wildemann and P. Oschmann, Thieme, Laboratory Diagnosis in Neurology, 2011.

M. Andersson, J. Alvarez-cermeño, G. Bernardi, I. Cogato, P. Fredman et al., Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report., Journal of Neurology, Neurosurgery & Psychiatry, vol.57, issue.8, pp.897-902, 1994.
DOI : 10.1136/jnnp.57.8.897

M. Freedman, E. Thompson, F. Deisenhammer, G. Giovannoni, G. Grimsley et al., Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis, Archives of Neurology, vol.62, issue.6, pp.865-70, 2005.
DOI : 10.1001/archneur.62.6.865

H. Reiber, E. Thompson, G. Grimsley, G. Bernardi, P. Adam et al., Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion, Clinical Chemistry and Laboratory Medicine, vol.41, issue.3, pp.331-338, 2003.
DOI : 10.1515/CCLM.2003.053

N. Gillain, A. Fumal, and J. Minon, Bandes oligoclonales et index IgG interprété selon Reiber dans les maladies inflammatoires du système nerveux central. Immuno-Anal Biol Spéc, pp.348-56, 2006.

M. Vaubourdolle and . Toxicologie, Sciences mathématiques, Physiques et Chimiques Wolters Kluwer France, 2007.

S. Desplat-jego, D. Bernard, I. Garnier-khalfallah, and J. Boucraut, Sclérose en plaques: diagnostic en, Feuill Biol, issue.235, pp.53-60, 2000.

H. Reiber, M. Otto, C. Trendelenburg, and A. Wormek, Reporting Cerebrospinal Fluid Data: Knowledge Base and Interpretation Software, Clinical Chemistry and Laboratory Medicine, vol.39, issue.4, pp.324-356, 2001.
DOI : 10.1515/CCLM.2001.051

G. Tibbling, H. Link, and S. Ohman, Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values, Scandinavian Journal of Clinical and Laboratory Investigation, vol.37, issue.5, 1977.
DOI : 10.3109/00365517709091496

K. Blennow, P. Fredman, A. Wallin, C. Gottfries, H. Frey et al., Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis, J Neurol Sci, 1994.

J. Souverijn, H. Serrée, R. Peet, G. Smit, W. Bruyn et al., Intrathecal immunoglobulin synthesis, Journal of the Neurological Sciences, vol.102, issue.1, pp.11-17, 1991.
DOI : 10.1016/0022-510X(91)90087-N

W. Tourtellotte, A. Potvin, J. Fleming, K. Murthy, J. Levy et al., Multiple sclerosis: Measurement and validation of central nervous system IgG synthesis rate, Neurology, vol.30, issue.3, pp.240-244, 1980.
DOI : 10.1212/WNL.30.3.240

V. Avettand-fenoel, N. Celton, M. Coulhon, and D. Duchassaing, ??tude immunologique des prot??ines du liquide c??phalorachidien dans le contexte de scl??rose en plaques??: comparaison de techniques qualitatives et quantitatives, Immuno-analyse & Biologie Sp??cialis??e, vol.17, issue.4, pp.242-50, 2002.
DOI : 10.1016/S0923-2532(02)01200-0

H. Reiber, Flow rate of cerebrospinal fluid (CSF) ??? A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases, Journal of the Neurological Sciences, vol.122, issue.2, pp.189-203, 1994.
DOI : 10.1016/0022-510X(94)90298-4

O. Delaroche, B. Evreux, E. Bigot-corbel, S. Wiertlewsky, F. Bailly et al., Étude biochimique du liquide céphalorachidien dans le cadre de la sclérose en plaques. Immuno-Anal Biol Spéc, pp.86-91, 2003.

C. Caudie, Bandes oligoclonales d'IgG dans les maladies neurologiques inflammatoires: aspects méthodologiques et apport diagnostique, Spectra Biol, issue.169, pp.63-72, 2008.

M. Tagajdid, M. Bouaiti, A. Dami, E. Machtani-idrissi, S. Bouhassain et al., Int??r??t de l???immunofixation du couple LCR/s??rum dans le diagnostic des maladies inflammatoires du syst??me nerveux central, Revue Neurologique, vol.167, issue.3, pp.225-255, 2011.
DOI : 10.1016/j.neurol.2010.10.001

S. Desplat, J. Pelletier, J. Pouget, F. Bellon, D. Bernard et al., Sensitized immunofixation: a new technique for analyzing the oligoclonal pattern of CSF immunoglobulins], Rev Neurol, vol.156, issue.10, pp.885-894, 2000.

C. Caudie, O. Allausen, and J. Bancel, Detection of oligoclonal IgG bands in in cerebrospinal fluid by immunofixation after electrophoretic migration in the automated Hydrasys sebia system, Ann Biol Clin, vol.58, issue.3, pp.376-385, 2000.

P. Mehta, Diagnostic Usefulness of Cerebrospinal Fluid in Multiple Sclerosis, Critical Reviews in Clinical Laboratory Sciences, vol.12, issue.3, pp.233-51, 1991.
DOI : 10.3109/10408369109106864

J. Boucraut, S. Desplat-jego, L. Duplan, J. Verdier, B. Michel et al., Cerebrospinal fluid in neurodegenerative dementia pathologies], Ann Biol Clin, 2000.

S. Halbgebauer, U. Haußmann, H. Klafki, H. Tumani, J. Wiltfang et al., Capillary isoelectric focusing immunoassay as a new nanoscale approach for the detection of oligoclonal bands, ELECTROPHORESIS, vol.60, issue.Suppl 5, pp.355-62, 2015.
DOI : 10.1002/elps.201400339

T. Wehr, 9 Capillary isoelectric focusing Separation Science and Technology [Internet] Academic Press, 2005.

G. Davies, G. Keir, E. Thompson, and G. Giovannoni, The clinical significance of an intrathecal monoclonal immunoglobulin band: A follow-up study, Neurology, vol.60, issue.7, 2003.
DOI : 10.1212/01.WNL.0000055864.08740.CB

C. Caudie, A. Birouk, J. Bancel, D. Claudy, L. Gignoux et al., Le profil cytoimmunologique du LCR lors du diagnostic pr??coce de la scl??rose en plaques, Pathologie Biologie, vol.53, issue.2, pp.68-74, 2005.
DOI : 10.1016/j.patbio.2004.04.001

D. Pohl, K. Rostasy, H. Reiber, and F. Hanefeld, CSF characteristics in early-onset multiple sclerosis, Neurology, vol.63, issue.10, pp.1966-1973, 2004.
DOI : 10.1212/01.WNL.0000144352.67102.BC

J. Rinker, K. Trinkaus, R. Naismith, and A. Cross, Higher IgG index found in African Americans versus Caucasians with multiple sclerosis, Neurology, vol.69, issue.1, pp.68-72, 2007.
DOI : 10.1212/01.wnl.0000265057.79843.d9

H. Reiber, Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler Houndmills Basingstoke Engl, pp.99-107, 1998.

R. Davenport and D. Keren, Oligoclonal bands in cerebrospinal fluids: significance of corresponding bands in serum for diagnosis of multiple sclerosis, Clin Chem, 1988.

J. Mares, R. Herzig, K. Urbanek, V. Sladkova, J. Sklenarova et al., Correlation of the igg index and oligoclonal bands in the cerebrospinal fluid of patients with multiple sclerosis, Biomedical Papers, vol.152, issue.2, 2008.
DOI : 10.5507/bp.2008.038

J. Ouallet, E. Bodiguel, C. Bensa, F. Blanc, D. Brassat et al., Recommendations for useful serum testing with suspected multiple sclerosis, Revue Neurologique, vol.169, issue.1, pp.37-46
DOI : 10.1016/j.neurol.2011.09.007

L. Villar, T. Masterman, B. Casanova, J. Gómez-rial, M. Espiño et al., CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis, Journal of Neuroimmunology, vol.211, issue.1-2, pp.101-105, 2009.
DOI : 10.1016/j.jneuroim.2009.03.003

A. Awad, B. Hemmer, H. Hartung, B. Kieseier, J. Bennett et al., Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis, Journal of Neuroimmunology, vol.219, issue.1-2, pp.1-7, 2010.
DOI : 10.1016/j.jneuroim.2009.09.002

J. Mandrioli, P. Sola, R. Bedin, M. Gambini, and E. Merelli, A multifactorial prognostic index in multiple sclerosis, Journal of Neurology, vol.66, issue.7, pp.1023-1054, 2008.
DOI : 10.1007/s00415-008-0827-5

J. Rinker, K. Trinkaus, and A. Cross, Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis, Neurology, vol.67, issue.7, pp.1288-90, 2006.
DOI : 10.1212/01.wnl.0000238107.31364.21

D. Zeman, P. Hradilek, P. Kusnierova, R. Piza, K. Reguliova et al., Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG, Biomedical Papers, 2014.
DOI : 10.5507/bp.2014.058

B. Kaplan, B. Aizenbud, S. Golderman, R. Yaskariev, and B. Sela, Free light chain monomers in the diagnosis of multiple sclerosis, Journal of Neuroimmunology, vol.229, issue.1-2, pp.263-71, 2010.
DOI : 10.1016/j.jneuroim.2010.09.002

E. Schuller and H. Sagar, Central nervous system IgG synthesis in multiple sclerosis Application of a new formula, Acta Neurologica Scandinavica, vol.97, issue.suppl, pp.365-71, 1983.
DOI : 10.1111/j.1600-0404.1983.tb03154.x

H. Reiber and K. Felgenhauer, Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system, Clinica Chimica Acta, vol.163, issue.3, pp.319-347, 1987.
DOI : 10.1016/0009-8981(87)90250-6

H. Reiber, The hyperbolic function: A mathematical solution of the protein flux/CSF flow model for blood-CSF barrier function a reply to the letter by, J. Neurol. Sci. J Neurol Sci, vol.126126, issue.2, pp.240-242243, 1994.

H. Reiber, Dynamics of brain-derived proteins in cerebrospinal fluid, Clinica Chimica Acta, vol.310, issue.2, pp.173-86, 2001.
DOI : 10.1016/S0009-8981(01)00573-3

H. Reiber and J. Peter, Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs, Journal of the Neurological Sciences, vol.184, issue.2, pp.101-123, 2001.
DOI : 10.1016/S0022-510X(00)00501-3

L. Villar, P. González-porqué, J. Masjuán, J. Alvarez-cermeño, A. Bootello et al., A sensitive and reproducible method for the detection of oligoclonal IgM bands, Journal of Immunological Methods, vol.258, issue.1-2, pp.151-156, 2001.
DOI : 10.1016/S0022-1759(01)00492-6

Y. Qin, P. Duquette, Y. Zhang, M. Olek, R. Da et al., Intrathecal B-Cell Clonal Expansion, an Early Sign of Humoral Immunity, in the Cerebrospinal Fluid of Patients with Clinically Isolated Syndrome Suggestive of Multiple Sclerosis, Laboratory Investigation, vol.100, issue.7, pp.1081-1089, 2003.
DOI : 10.1056/NEJM199801293380502

F. Joseph, C. Hirst, T. Pickersgill, Y. Ben-shlomo, N. Robertson et al., CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients, Journal of Neurology, Neurosurgery & Psychiatry, vol.80, issue.3, pp.292-298, 2009.
DOI : 10.1136/jnnp.2008.150896

I. Mero, M. Gustavsen, H. Saether, S. Flåm, P. Berg-hansen et al., Oligoclonal Band Status in Scandinavian Multiple Sclerosis Patients Is Associated with Specific Genetic Risk Alleles, PLoS ONE, vol.55, issue.3, p.58352, 2013.
DOI : 10.1371/journal.pone.0058352.s004

S. Siritho and M. Freedman, The prognostic significance of cerebrospinal fluid in multiple sclerosis, Journal of the Neurological Sciences, vol.279, issue.1-2, pp.21-26, 2009.
DOI : 10.1016/j.jns.2008.12.029

A. Goris, I. Pauwels, M. Gustavsen, B. Van-son, K. Hilven et al., Genetic variants are major determinants of CSF antibody levels in multiple sclerosis, Brain, vol.138, issue.3, pp.632-675
DOI : 10.1093/brain/awu405

K. Imrell, A. Landtblom, J. Hillert, and T. Masterman, Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct, Neurology, vol.67, issue.6, pp.1062-1066, 2006.
DOI : 10.1212/01.wnl.0000237343.93389.35

S. Kikuchi, T. Fukazawa, M. Niino, I. Yabe, R. Miyagishi et al., HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen, Neurology Feb, vol.2560, issue.4, pp.647-51, 2003.

M. Koch, D. Heersema, J. Mostert, A. Teelken, D. Keyser et al., Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis, European Journal of Neurology, vol.56, issue.7, pp.797-800, 2007.
DOI : 10.1212/01.wnl.0000237343.93389.35

P. Lourenco, A. Shirani, J. Saeedi, J. Oger, W. Schreiber et al., Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression, Multiple Sclerosis Journal, vol.29, issue.5, 2013.
DOI : 10.1212/WNL.0b013e3182190f74

A. Moroso, M. Deloire, A. Ruet, J. Ouallet, R. Casey et al., Does cerebrospinal fluid analysis add predictive value to magnetic resonance imaging for long term irreversible disability in patients with early multiple sclerosis?, Journal of the Neurological Sciences, vol.354, issue.1-2, 2015.
DOI : 10.1016/j.jns.2015.04.044

E. Andreadou, S. Chatzipanagiotou, V. Constantinides, A. Rombos, E. Stamboulis et al., Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis, Clinical Neurology and Neurosurgery, vol.115, issue.10, pp.2094-2102, 2013.
DOI : 10.1016/j.clineuro.2013.07.026

S. Yoshimura, N. Isobe, T. Yonekawa, T. Matsushita, K. Masaki et al., Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients, PLoS ONE, vol.45, issue.11, p.48592, 2012.
DOI : 10.1371/journal.pone.0048592.s004

D. Seze, J. Papeix, and C. , Syndrome clinique isolé à IRM normale. Prat Neurol -FMC, pp.19-21, 2010.